申请人:Almirall Prodesfarma S.A.
公开号:US07189741B2
公开(公告)日:2007-03-13
The invention relates to indolyl piperidinyl derivatives of formula (I) wherein: A1 represents an alkylene, alkyleneoxy, alkylenethio, alkanoylene or hydroxyalkylene group; A2 represents an alkylene, alkyleneoxy, alkylenethio, alkanoylene or an alkyleneoxyalkylene group; W1 represents a phenylene, furanylene or pyridinylene group which is unsubstituted or substituted by one or more halogen atoms, alkoxy groups and/or alkyl groups; W2 represents a 3–10 membered monocyclic or bicyclic group containing from 1 to 3 heteroatoms said group being unsubstituted or substituted by one or more halogen atoms, alkyl groups, alkoxy groups and/or oxo groups; R1 represents a hydrogen or halogen atom or an alkyl, alkoxy or methylamino group; and R2 represents a carboxyl group; and pharmaceutically acceptable salts thereof; to processes for their preparation; to pharmaceutical compositions containing them; and to their medical use as antihistaminic and antiallergic agents.
本发明涉及式(I)的吲哚基哌啶衍生物,其中:A1代表烷基,烷氧基,烷硫基,酰基烷基或羟基烷基;A2代表烷基,烷氧基,烷硫基,酰基烷基或烷氧基烷基;W1代表苯基,呋喃基或吡啶基,其未取代或被一个或多个卤素原子,烷氧基和/或烷基取代;W2代表一个含1-3个杂原子的3-10环的单环或双环基团,其未取代或被一个或多个卤素原子,烷基,烷氧基和/或氧代基取代;R1代表氢或卤素原子或烷基,烷氧基或甲基氨基基团;R2代表羧基;以及其药学上可接受的盐;本发明还涉及制备它们的过程,含有它们的制药组合物以及它们作为抗组胺和抗过敏剂的医药用途。